European Companies Search Engine
EU funding (€8,499,556): Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models Hor1 Oct 2024 EU Research and Innovation programme "Horizon"
Overview
Text
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim a. Rhein, Germany.
The visualizations for "BOEHRINGER INGELHEIM PHARMA GmbH & Co. KG - EU funding (€8,499,556): Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.